Spring Creek Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-22,602
Closed -$1.25M 120
2018
Q2
$1.25M Buy
+22,602
New +$1.22M 0.15% 73

Other funds holding BMY

Spring Creek Capital's BMY Position: Q3 2018 in Review

Spring Creek Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 22,602 shares — an estimated $1.25M sold.

Spring Creek Capital first reported a position in BMY in Q2 2018 and held it in 1 quarter. The position peaked at $1.25M in Q2 2018. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Spring Creek Capital reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
  • Spring Creek Capital sold 22,602 Bristol-Myers Squibb shares in Q3 2018, an estimated $1.25M.
  • Spring Creek Capital first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 1 quarter.
  • Spring Creek Capital's Bristol-Myers Squibb position peaked at $1.25M in Q2 2018.
  • 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.